Secondary hyperparathyroidism is characterized by an increase in parathyroid (PT) cell number, and parathyroid hormone (PTH) synthesis and secretion. It is still unknown as to what stimuli regulate PT cell proliferation and how they do this. We have studied rats with dietary-induced secondary hyper-and hypoparathyroidism, rats given 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and rats after 5/6 nephrectomy for the presence of PT cell proliferation and apoptosis. PT cell proliferation has been measured by staining for proliferating cell nuclear antigen (PCNA) and apoptosis by in situ detection of nuclear DNA fragmentation and correlated with serum biochemistry and PTH mRNA levels. A low calcium diet led to increased levels of PTH mRNA and a 10-fold increase in PT cell proliferation. A low phosphate diet led to decreased levels of PTH mRNA and the complete absence of PT cell proliferation. 1,25(OH)2D3 (25 pmol/d x 3) led to a decrease in PTH mRNA levels and unlike the hypophosphatemic rats there was no decrease in cell proliferation. There were no cells undergoing apoptosis in any of the experimental conditions. The secondary hyperparathyroidism of 5/6 nephrectomized rats was characterized by an increase in PTH mRNA levels and PT cell proliferation which were both markedly decreased by a low phosphate diet. The number of PCNA positive cells was increased by a high phosphate diet. Therefore hypocalcemia, hyperphosphatemia and uremia lead to PT cell proliferation, and hypophosphatemia completely abolishes this effect. Injected 1,25(OH)2D3 had no effect.
Introduction
In the normal parathyroid gland very few cells proliferate (1) . In secondary hyperparathyroidism there is an increase in para-thyroid (PT)' cell number, in addition to the major increase in the function of each cell to express more parathyroid. hormone (PTH) mRNA and secrete more PTH. The stimuli which lead to increased PTH gene expression, translation and secretion are well characterized. In vivo, these include low calcium, high phosphate and estrogens (2) (3) (4) . The factors which lead to decreased PTH gene expression in vivo are 1,25-dihydroxyvitamin D3 (1, 25 (OH)2D3) (5) and low phosphate (3) . In vitro the action of 1,25-dihydroxyvitamin D3 can be enhanced by retinoic acid (6) . The stimuli to PT cell hyperplasia are less well de- fined.
Parfitt (1) has analyzed the literature on PT cell replication, and concluded that after cessation of growth, few PT cells divide more than twice, and many do not divide at all. He suggested that since the adult PT cell number does not change, the very slow rate of cell gain must be balanced by a correspondingly slow rate of cell loss ( 1) . The parathyroid normally has very few mitoses but it has the potential to replicate after stimuli such as a chronically low serum calcium (2) . An analogous situation might be the adrenal cortex which becomes hyperplastic after chronic stimulation with its trophic hormone, adrenal cortical trophic hormone (ACTH), or the thyrotrophic cells of the pituitary which become hyperplastic after thyroidectomy without thyroxin replacement therapy. This indicates that these cells retain a stem cell potential which is normally not expressed. Stereoscopic electron microscopy studies have shown that the parathyroid cells of rats fed a low calcium diet for 3 wk are hypertrophied (7, 8) , and flow cytometry estimation of parathyroid cell number showed that there was a large increase in PTH gene expression per cell and only a moderate increase in parathyroid cell number (2) . However, patients with chronic renal failure are maintained on hemodialysis treatment for years and in this situation the parathyroid cell hyperplasia becomes a major clinical problem resulting in the synthesis of large amounts of PTH (9, 10) . This excess PTH leads to tremendous bone resorption, osteitis fibrosa cystica, which is a central feature of renal osteodystrophy. It is therefore of prime clinical importance to understand the pathogenesis of PT cell hyperplasia and to determine what causes the PT cell to proliferate.
The onset of DNA replication and mitosis, the two key cellcycle events is a tightly controlled event. In yeast and eukaryotic cells in culture there is a cascade of cyclins (D, E, A, B) which are sequentially activated to take the cell through the different phases of the cell cycle. Their activity is in balance with those of cyclin kinase inhibitors, such as p27 and p21, and when the activities of the different cyclin kinases exceed that of the inhibitors then the cell enters the cell cycle (11) . The human nuclear protein, proliferating cell nuclear antigen (PCNA), so 1 . Abbreviations used in this paper: PCNA, proliferating cell nuclear antigen; PT, parathyroid; TUNEL, terminal deoxynucleotidyl transferase (TdT) -mediated dUTP-biotin nick end labeling. named because of its initial discovery as a cell-cycle dependent antigen (12) , is a cofactor of DNA polymerase 6 (13) . PCNA is important in cellular DNA synthesis and in cell cycle progression where it acts as a processivity factor or sliding clamp for DNA polymerase 6 (14) . Crystal structure of PCNA shows that three PCNA molecules encircle duplex DNA, providing a DNAbound platform for the attachment of the polymerase (15) . Antisense oligonucleotides to PCNA added to exponentially growing Balb/c3T3 cells completely suppressed their growth ( 16) . When cells enter the cell cycle and are proliferating their nuclei stain positively for PCNA and this immunohistochemical test is now a sensitive test for cell proliferation in histology sections (17) . We have used PCNA staining to characterize the regulators of cell proliferation in the parathyroid from rats fed diets with different amounts of calcium, phosphate and vitamin D, both in normal rats and rats with chronic renal failure due to 5/6 nephrectomy. The results show that in those situations where there is an increase in PTH mRNA and serum PTH, such as hypocalcemia, hyperphosphatemia and chronic renal failure, there was an increase in PT cell proliferation. In an experimental model where there is a decrease in PTH mRNA due to hypophosphatemia there was a complete absence of proliferation, however, after 1,25(OH)2D3 at a dose which decreased PTH mRNA there was no change in the number of proliferating PT cells.
Programmed cell death or apoptosis is associated with endogenous endonuclease activity which results in the cleavage of chromatin at linker DNA sites between nucleosomes (18, 19 (21) . The 5/6 nephrectomized rats were then fed diets with different phosphate contents as above for two weeks after the second operation.
Measurement of cellular mRNA levels RNA was extracted from rat thyroparathyroid tissue and the levels of PTH mRNA were measured by Northern blots after extraction with TRI Reagent (Molecular Research Center Inc., Cincinnati, Ohio). RNA was denatured and ethidium bromide was added to each sample at a concentration of 0.1 mg/mil. The samples were size-fractionated by electrophoresis on 1.25% agarose gels containing formaldehyde and transferred to Hybond filters (Amersham, England) by diffusion blotting. The integrity of the RNA and the uniformity of RNA transfer to the membrane were determined by UV visualization of the ribosomal RNA bands of the gels and the filters. The filters were fixed by UV cross-linking and hybridized as previously described (4, 5) . Hybridization was to a random primed rat PTH cDNA (a gift of H. Meyer, GBF, Braunschweig, Germany) and 18S RNA (gift of M. A. Levine, Baltimore, MD).
Immunohistochemistry
Proliferating cell nuclear antigen (PCNA). Paraffin tissue blocks were cut to 4-6-mm-thick sections, deparaffinized in xylene and alcohols, and placed for 15 min in alcohol-H202, 3%, for blocking endogenous peroxidase. To reveal masked antigens in formalin-fixed, paraffin-embedded tissue sections, slides were placed in citrate buffer (pH 6.0) and treated in the microwave at 920C for 10 min. After removing container from the microwave and cooling for 15 min, slides were placed in PBS (pH 7.6). Sections were then treated with Bovine Serum Albumin (BSA) to prevent background staining, and incubated for one hour with the primary antibody PCNA-PC-10 (Zymed Laboratories, Inc., San Francisco, CA) at room temperature in a humidified chamber (22, 23) . Slides were rinsed with PBS for 3-4 min and incubated with the biotinylated linked antibody for 30 min and with the labeling reagent peroxidase conjugated streptavidin for 30 min (Bio Genex Laboratories, San Ramon, CA). After rinsing, the peroxidase label was demonstrated using 3-amino-9-ethyl carbazole (AEC) for 15 min, and counterstained with Mayer Hematoxylin. AEC produces a red end-product that is soluble in alcohol and is used with an aqueous mounting media (kaiser's glycerol gelatin). A negative control was run using the same technique but omitting the primary antibody and adding the streptavidin-biotin complex. PCNA positive cells were counted per microscope field with the PT section completely filling the microscope field. For each rat four microscope fields were counted and the mean used. The variation amongst sections in each rat was always < 10%. Each group represents the mean±SEM of 4-5 rats.
DNA nick end labeling of tissue sections
This was performed essentially as described (20) . Tissue sections were treated with proteinase K, washed four times, treated with 2% H202, rinsed and immersed in buffer with biotinylated dUTP and rinsed. The sections were covered with Extra-avidin peroxidase (BioMakor, Rehovot, Israel), washed and stained with AEC for 30 min (20) .
Serum measurements
Serum calcium and phosphate were measured in a Roche autoanalyzer. Serum Table I shows the serum biochemistry in the weanling rats fed the different diets for 3 wk. Serum calcium was decreased in the rats fed a low calcium diet and increased in rats fed a low phosphate diet. Serum phosphate only changed in the rats fed a low phosphate diet where it was decreased. Serum 1,25 (OH)2D3 was markedly increased in rats fed both the low calcium and the low phosphate diets, and decreased by the high phosphate diet.
PTH mRNA levels were increased in the rats fed the low (21) . A high phosphate diet did not increase serum phosphate (Table II) or PTH mRNA levels significantly (Fig. 4) . A low phosphate diet led to a decrease in serum phosphate and an increase in serum calcium (Table  II) and with this there was a marked decrease in PTH mRNA levels (Fig. 4) . There was no change in a control gene 18 S RNA (not shown). Serum 1,25 (OH)2D3 levels were increased by a low phosphate diet (95+9: 165±+12 pg/ml; control: low phosphate; mean±SE (n = 4), P < 0.01). PCNA staining of parathyroid tissue from these rats showed a small number of positive cells in control mature rats with normal renal function, an increased number of PCNA positive cells in 5/6 nephrectomized rats fed a control diet and this was further increased by a high phosphate diet (Figs. 5 and 6 ). The 5/6 nephrectomized rats fed a low phosphate diet had a marked reduction in the number of PCNA positive cells to numbers even less than control rats with normal renal function (Figs. 5 and 6 (n = 5), P < 0.01) as previously reported (5) . There was no change in the number of PCNA staining positive cells (Fig. 2) .
Therefore, in this situation where there was a decrease in PTH In many situations where there is accelerated cell proliferation there is a corresponding accelerated cell apotosis such as in the small intestine. We therefore studied whether there were PT cells undergoing apoptosis in these experimental models of dietary hyper-and hypoparathyroidism. Rats fed diets with a low calcium, low and high phosphate as well as rats after three daily injections of 1,25 (OH)2D3 (25 pmol daily) were studied. In all the groups studied there were no apoptotic cells seen by the TUNEL method (not shown). As a control for the accuracy of the TUNEL method small intestine from normal rats and malignant melanoma and breast cancer tissues were studied at the same time. They all showed the expected number of apoptotic cells (20) . Therefore, the PT gland is characterized by the ability to respond by increasing or decreasing PTH gene expression, PTH secretion and PT cell proliferation. There was no evidence of PT cell programmed cell death as measured by the TUNEL method after changes in dietary calcium and phosphate and injections of 1,25 (OH)2D3 in the present experiments. The TUNEL method is reported to be an accurate measure of DNA nicks present in apoptotic cells but the classic definition of apoptosis is by morphology which was not studied here.
Discussion
PCNA staining of nuclei is a sensitive and reliable index of the S phase of cell proliferation which is now routinely used in the study of human pathology specimens ( 17) . Previous studies on PT cell hyperplasia have used relatively insensitive techniques such as counting mitoses (24) or flow cytometry determination of PT cell number after dispersion of PT glands into single cells (2) . The PCNA staining provides a sensitive and reproducible measurement of PT cell proliferation although a possible limitation of the methodology is that it may also measure DNA repair. Dietary hypocalcemia leads to secondary hyperparathyroidism with marked increases in PTH mRNA and serum PTH levels (2) . In the present study there was the same increase in PTH mRNA and with this there was an increase in PT cell proliferation as measured by PCNA at both 10 There were four rats in each group. * P < 0.05 and I P < 0.01 compared with 5/6 NX control diet.
hormone and has a transcriptional effect on the PTH gene both in vivo and in vitro (5, 25) . In vivo both calcium and phosphate have a post-transcriptional effect (3, 26) . In vitro a calcium responsive element has been characterized in the PTH gene suggesting a transcriptional role but its physiological relevance has not been determined (22) . Calcium regulates the PT cell by binding to a calcium sensor on the cell membrane which activates phospholipase C (27), and it is not known by what mechanism phosphate regulates the PT cell. It might be directly or indirectly via a factor which is not serum calcium or 1,25 (OH)2D3 (3). In any event the present study clearly shows that hypocalcemic rats have an increased PT cell proliferation and hypophosphatemic rats a decreased PT cell proliferation. These findings are relevant to the pathogenesis of secondary hyperparathyroidism and its treatment. Transient increases in intracellular calcium may have a role in the progression of the cell through mitosis possibly mediated by changes in calmodulin concentration (28) , but what is of particular interest in our present study on the PT is that the stimulus to proliferation was a low serum calcium and this has been shown to be associated with a decrease in intracellular calcium in the PT (29) . In tissues with a high proliferation index such as small intestine or dormant metastases there is a steady state where cell proliferation is balanced by cell death (30) . Cell death could be a result of necrosis which was not observed in parathyroids or programmed cell death. Programmed cell death or apoptosis differs from necrosis in that it is characterized by single cell death in the midst of living cells (19) . Apoptosis was studied in situ at a cellular level by labeling fragmented DNA with the terminal deoxynucleotidyl transferase (TdT) labeling technique (20) . There were no apoptotic cells in the parathyroids from rats with secondary hyperparathyroidism due to a low calcium diet, experimental renal failure or a high phosphate diet. There were also no cells undergoing apoptosis in the parathyroids of rats with secondary hypoparathyroidism due to a low phosphate diet nor in those injected with 1,25 (OH )2D3. Tissues with known apoptosis such as the small intestine, melanoma and breast cancer were studied at the same time and they had their expected apoptotic indices. Therefore, in these . Chronic renal failure (CRF) increases parathyroid cell proliferation and this is further increased by a high phosphate diet and decreased by a low phosphate diet. Mature rats underwent 5/6 nephrectomy and were fed normal, low or high phosphate diets before study. (36) . In all these clinical situations the stimulus was hypocalcemia but hyperphosphatemia may have an independent role. Serum phosphate is invariably raised in chronic renal failure and correction of serum phosphate alone with no changes in serum calcium or 1,25(OH)2D3 corrects secondary hyperparathyroidism (39) (40) (41) and it is possible but not proven that phosphate may have a direct effect on the PT cell similar to that of calcium (3) . In patients with intestinal malabsorption both the serum calcium and 1,25 (OH)2D3 levels would be decreased. Therefore, chronic hypocalcemia is the one recognized factor which is shared by these different clinical conditions which lead to parathyroid cell hyperplasia.
The mechanisms of PT cell proliferation in primary hyperparathyroidism and in some PT adenomas (42, 43) and all PT carcinomas (44) have been elucidated and they may be relevant to the development of secondary or more likely tertiary hyperparathyroidism (45) . Primary hyperparathyroidism may result from a number of different molecular mechanisms such as in patients with familial hypocalciuric hypercalcemia (FHH) (46, 47) where there is a mutation in the gene coding for the PT calcium sensor (48) , or in multiple endocrine neoplasia where the clonal proliferating PT cells contain deletions on the long arm of chromosome 11 (type 1) (49, 50), or inherited mutations in the RET oncogene (type 2) (51-53). These inherited molecular changes are associated with hyperplasia of all four PT glands similar to the secondary hyperplasia of chronic renal failure. Most hemodialysis patients with uremic refractory hyperparathyroidism were shown by Arnold et al to have at least one monoclonal parathyroid tumor (54) , which suggests that neoplastic transformation of preexisting polyclonal hyperplasia may have led to these monoclonal growths (54) .
Therefore, the PT cell may be stimulated to proliferate under appropriate physiological stimuli such as a low serum calcium, and pathological stimuli such as a genetic alteration in mediators of signal transduction, the cell cycle or absence of a tumor suppressor gene where it has the potential to proliferate and even transform into a malignant cell. It is these lessons which are now being applied to an understanding of PT cell proliferation in the secondary hyperparathyroidism of chronic renal failure in order to design effective preventative and therapeutic measures.
